Browse > Article
http://dx.doi.org/10.3961/jpmph.2009.42.6.408

Mumps Transmission Control Status and Inapparent Infection Rate among Middle and High School Students during the 2007-2008 Mumps Outbreak in Daegu  

Kim, Kyo-Hyun (Department of Preventive Medicine, Eulji University School of Medicine)
Kim, Chang-Hwi (Department of Pediatrics, Sunchunhyang University, College of Medicine)
Choi, Bo-Youl (Department of Preventive Medicine, Hanyang University, College of Medicine)
Go, Un-Yeong (Korea Center for Disease Control and Prevention)
Lee, Dong-Han (Korea Center for Disease Control and Prevention)
Ki, Mo-Ran (Department of Preventive Medicine, Eulji University School of Medicine)
Publication Information
Journal of Preventive Medicine and Public Health / v.42, no.6, 2009 , pp. 408-415 More about this Journal
Abstract
Objectives : This study was performed to investigate the mumps transmission control status and inapparent infection rate among middle and high school students in Daegu City during a mumps outbreak. Methods : Nine schools (two middle schools and seven high schools), which reported a number of mumps cases between 2007 and 2008 were selected for investigation. During March-May 2008, a standard questionnaire was distributed to gather information about case identification, instructed isolation measure, isolation status of mumps cases and related factors, and outdoor activities of nonisolated mumps case. Inapparent infection rate was estimated by serum mumps IgM and IgG antibodies status and self-reported mumps symptoms in three of the nine schools. Results : Among 2,560 respondents, more than half of students answered that they did not receive instructions in mumps transmission control measures during the outbreak. Among the 327 mumps cases identified by the questionnaire, 131 cases (40.1%) were considered as isolated and the isolation rates were significantly different among schools, grades, and gender. Of the non-isolated cases, 88.3% continued attending school. Inapparent mumps infection rates were between 56.3% and 70.2%. Conclusions : Mumps transmission control was inadequate to control the mumps outbreak. Although high inapparent infection rate would mitigate the transmission control effect of case isolation, this measure is fundamental for infection control. The reasons of this inadequate status need to be explored to develop an effective intervention strategy.
Keywords
Mumps; Disease outbreaks; Infection control; Patient isolation;
Citations & Related Records
Times Cited By KSCI : 1  (Citation Analysis)
Times Cited By SCOPUS : 1
연도 인용수 순위
1 Centers for Disease Control and Prevention. Mumps. In: Centers for Disease Control and Prevention, editors. Epidemiology and Prevention of Vaccine-preventable Diseases: Pink Book. 10th ed. Wahsington, DC: Public Health Foundation; 2008. p. 149-158
2 Peltola H, Davidkin I, Paunio M, Valle M, Leinikki P, Heinonen OP. Mumps and rubella eliminated from Finland. JAMA 2000; 284(20): 2643-2647   DOI   ScienceOn
3 World Health Organization. Global status of mumps immunization and surveillance. Wkly Epidemiol Rec 2005; 80(48): 418-424
4 Galazka AM, Robertson SE, Kraigher A. Mumps and mumps vaccine: A global review. Bull World Health Organ 1999; 77(1): 3-14   PUBMED
5 Peltola H, Kulkarni PS, Kapre SV, Paunio M, Jadhav SS, Dhere RM. Mumps outbreaks in Canada and the United States: Time for new thinking on mumps vaccines. Clin Infect Dis 2007; 45(4): 459-466   DOI   ScienceOn
6 Cohen C, White JM, Savage EJ, Glynn JR, Choi Y, Andrews N, et al. Vaccine effectiveness estimates, 2004-2005 mumps outbreak, England. Emerg Infect Dis 2007; 13(1): 12-17   PUBMED
7 Kim MH, Ki M, Hu YJ, Choi BY. An epidemiologic investigation on mumps outbreak in Cheju-do, 1998. Korean J Prev Med 2001; 34(1): 89-99. (Korean)   과학기술학회마을
8 Savitz DA, Measurement and classification of exposure. In: Savitz DA, editor. Interpreting Epidemiologic Evidence: Strategies for Study Design and Analysis. 1st ed. New York: Oxford University Press; 2003. p. 163-204
9 Plotkin S, Wharton M. Mumps vaccine. In: Plotkin AP, Offit PA, Orenstein WA, editors. Vaccines. 5th ed. Philadelphia: WB Saunders; 2008. p. 441-470
10 Krause CH, Molyneaux PJ, Ho-Yen DO, McIntyre P, Carman WF, Templeton KE. Comparison of mumps-IgM ELISA in acute infection. J Clin Virol 2007; 38(2): 153-156   DOI   ScienceOn
11 Choi BY, Shin YJ, Son JI, Ki M, Oh YW, Bang KN, et al. Epidemiological study on the mumps epidemic - in one primary school in Hwasung-gun, Kyonggi-do. Korean J Epidemiol 1995; 17(1): 105-115. (Korean)
12 Soud FA, Cortese MM, Curns AT, Edelson PJ, Bitsko RH, Jordan HT, et al. Isolation compliance among university students during a mumps outbreak, Kansas 2006. Epidemiol Infect 2009; 137(1): 30-37   DOI   ScienceOn
13 Polgreen PM, Bohnett LC, Cavanaugh JE, Gingerich SB, Desjardin LE, Harris ML, et al. The duration of mumps virus shedding after the onset of symptoms. Clin Infect Dis 2008; 46(9): 1447-1449   DOI   ScienceOn
14 Dayan GH, Quinlisk MP, Parker AA, Barskey AE, Harris ML, Schwartz JM, et al. Recent resurgence of mumps in the United States. N Engl J Med 2008; 358(15): 1580-1589   DOI   ScienceOn
15 Sanz JC, Mosquera Mdel M, Echevarria JE, Fernandez M, Herranz N, Palacios G, et al. Sensitivity and specificity of immunoglobulin G titer for the diagnosis of mumps virus in infected patients depending on vaccination status. APMIS 2006; 114(11): 788-794   DOI   ScienceOn
16 Department of Health and Human Services. Healthy People 2010: Understanding and Improving Health. Washington DC: Department of Health and Human Services; 2000 [cited 2009 Jan 22]. Available from: URL: www. healthypeople.gov/document/html/objectives/14-01.htm
17 Cortese MM, Jordan HT, Curns AT, Quinlan PA, Ens KA, Denning PM, et al. Mumps vaccine performance among university students during a mumps outbreak. Clin Infect Dis 2008; 46(8): 1172-1180   DOI   ScienceOn
18 Centers for Disease Control and Prevention. Updated recommendations for isolation of persons with mumps. MMWR Morb Mortal Wkly Rep 2008; 57(40): 1103-1105   ScienceOn
19 Richardson M, Elliman D, Maguire H, Simpson J, Nicoll A. Evidence base of incubation periods, periods of infectiousness and exclusion policies for the control of communicable diseases in schools and preschools. Pediatr Infect Dis J 2001; 20(4): 380-391   DOI   ScienceOn
20 Korea Centers for Disease Control and Prevention, Korean Medical Association, Korea Advisory Committe on Immunization Practices. Epidemiology and Prevention of Vaccine-prevantable Disease. Seoul: Korea Centers for Disease Control and Prevention; 2006. p. 163-202. (Korean)
21 Ki M, Kim CH, Choi BY, Kang C, Lee DH, Park O, et al. Evaluation of mumps outbreak and serology. Seoul: Korea Center for Diseases Control and Prevention; 2008. (Korean)
22 Gemmill I. Mumps vaccine: Is it time to reevaluate our approach? CMAJ 2006; 175(5):491-492   DOI   ScienceOn
23 Borchardt S, Rao P, Dworkin M. Compliance with exclusion requirements to prevent mumps transmission. Emerg Infect Dis 2007; 13(10): 1617-1618   DOI   ScienceOn
24 Dayan GH, Rubin S. Mumps outbreaks in vaccinated populations: are available mumps vaccines effective enough to prevent outbreaks? Clin Infect Dis 2008; 47(11): 1458-1467   DOI   ScienceOn
25 Park BC, Cheong HK, Lim HS, Kim DS, Kim Dh. Epidemiologic investigation of a mumps outbreak in a middle school in Pohang, Korea. Korean J Epidemiol 2000; 22(2): 148-158. (Korean)
26 Watson-Creed G, Saunders A, Scott J, Lowe L, Pettipas J, Hatchette TF. Two successive outbreaks of mumps in nova scotia among vaccinated adolescents and young adults. CMAJ 2006; 175(5): 483-488   DOI   ScienceOn
27 Gupta RK, Best J, MacMahon E. Mumps and the UK epidemic 2005. BMJ 2005; 330(7500): 1132-1135   DOI   ScienceOn
28 Hviid A, Rubin S, Mulemann K. Mumps. Lancet 2008; 371(9616): 932-944   DOI   ScienceOn
29 Vandermeulen C, Mathieu R, Geert LR, Pierre VD, Karel H. Long-term persistence of antibodies after one or two doses of MMRvaccine. Vaccine 2007; 25(37-38): 6672-6676   DOI   ScienceOn
30 Davidkin I, Jokinen S, Broman M, Leinikki P, Peltola H. Persistence of measles, mumps, and rubella antibodies in an MMR-vaccinated cohort: A 20-year follow-up. J Infect Dis 2008; 197(7): 950-956   DOI   ScienceOn
31 Kim KH, Ki H, Choi BY, Kim CH, Lee DH, Ko UY, et al. Evaluation of mumps vaccine effectiveness by outbreak investigation in one kindergarten in Ulsan city, 2006. Korean J Epidemiol 2008; 30(1): 110-118. (Korean)   DOI   ScienceOn
32 Choi BY. Epidemiologic characteristics and management of infectious disease. In: Committee on publication of preventive medicine textbook, editor. Preventive Medicine. 3rd ed. Seoul: Gye Chuk Mun Wha Sa Publishing Co.; 2004. p. 177-267. (Korean)
33 Centers for Disease Control and Prevention, editor. Manual for the Surveillance of Vaccinepreventable Diseases. 4th ed. Atlanta: Disease Control and Preven-tion; 2008
34 Baum SG. Editorial commentary: Who cares about mumps? You should! Clin Infect Dis 2008; 46(9): 1450-1451   DOI   ScienceOn
35 Korea Centers for Disease Control and Prevention. 2007 Communicable Diseases Surveillance Yearbook. Seoul: Korea Centers for Disease Control and Prevention; 2008. (Korean)
36 Marin M, Quinlisk P, Shimabukuro T, Sawhney C, Brown C, LeBaron CW. Mumps vaccination coverage and vaccine effectiveness in a large outbreak among college students- Iowa, 2006. Vaccine 2008; 26(29-30): 3601-3607   DOI   ScienceOn